ARPA-H’s BoSS Program Funds Three Teams Tackling Cold Chain Challenges for Cell Therapies
Cell therapies and other biologics depend on ultracold storage and tightly controlled shipping. ARPA-H has funded teams of companies, research agencies, and universities developing alternatives, aiming to widen patient access to these therapies.